IRCT20180203038601N1 IRCT 2018-04-08 Shiraz University of Medical Sciences The effect of Lu-177-EDTMP-Sm-153 complex on bone pain palliation Metastatic bone pain palliation using 177Lu/153Sm-EDTMP cocktail: a clinical trial 2015-11-22 anticipated 30 Complete https://irct.ir/trial/29442 interventional Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Treatment. 2-3 Pain caused by bone metastases. The 177Lu /153Sm-EDTMP cocktail is prepared from the Iran Atomic Energy Organization and 0.5 mCi/ kg of each radioactive substance is injected for the patients with bone metastases who fill out informed consent form . The drug is administered as a single injection and patients will be followed up for 12 weeks (3 months). Patients are weekly evaluated for pain and side effects and pain score form will be filled for pain assessment. CBC test will be performed weekly to assess the most common side-effect that is bone marrow suppression. At the end of three months, all patients are evaluated for the effect of the drug and the amount of bone marrow suppression.. Yes - There is a plan to make this available What will be shared: The data is related to the thesis When: 6 Months To whom: Supervisors and project partners Conditions: after pressing the data Where to obtain: Project manager How to obtain: Sending email to the project manager Comments: